Your browser doesn't support javascript.
loading
Seroprevalencia de HTLV-I/II y factores de riesgo asociados a la infección en la población de donantes de sangre de Córdoba, Argentina / HTLV-I/II seroprevalence and risk factors associated with infection in a blood donor population in Córdoba, Argentina
Gallego, S; Maturano, E; Recalde, A; Gastaldello, R; Sileoni, S; Bepre, H; Medeot, S.
  • Gallego, S; Universidad Nacional de Córdoba. Facultad de Ciencias Médicas. AR
  • Maturano, E; Universidad Nacional de Córdoba. Facultad de Ciencias Médicas. AR
  • Recalde, A; Universidad Nacional de Córdoba. Facultad de Ciencias Médicas. AR
  • Gastaldello, R; Universidad Nacional de Córdoba. Facultad de Ciencias Médicas. AR
  • Sileoni, S; Universidad Nacional de Córdoba. Facultad de Ciencias Médicas. AR
  • Bepre, H; Universidad Nacional de Córdoba. Facultad de Ciencias Médicas. AR
  • Medeot, S; Universidad Nacional de Córdoba. Facultad de Ciencias Médicas. AR
Rev. argent. microbiol ; 33(3): 182-186, jul.-sept. 2001.
Article in Spanish | LILACS | ID: lil-332482
ABSTRACT
In this study we have determined the seroprevalence of infections by HTLV-I/II in the blood donor population from the city of Córdoba. A total of 5476 blood donor sera were screened for HTLV-I/II antibodies by particle agglutination assay (PA) (SERODIA HTLV-I, Fujirebio INC, Tokyo, Japan). The reactive sera samples were confirmed by an "in house" indirect immunofluorescence assay (IFA). 14 out of 5476 blood donors studied were PA reactive and were confirmed positive by IFA, showing a prevalence of 0.26 (95 confidence interval 0.126-0.394). All the positive samples, except one, met the criteria for HTLV-I. Although one HTLV-I infected donor was an intravenous drug abuser and two donors were born in highly endemic areas for HTLV-I, no specific risk factors were identified among the others. The demonstration that HTLV-I circulates in blood donor population of Córdoba, points out that the systematic screening of blood for HTLV-I/II antibodies must be implemented in the blood banks, in an attempt to prevent the spread of infections with this oncogenic virus in Argentina.
Subject(s)
Search on Google
Index: LILACS (Americas) Main subject: Blood Donors / HTLV-I Antibodies / HTLV-I Infections / HTLV-II Antibodies / HTLV-II Infections Type of study: Etiology study / Prognostic study / Risk factors / Screening study Limits: Adolescent / Adult / Female / Humans / Male Country/Region as subject: South America / Argentina Language: Spanish Journal: Rev. argent. microbiol Journal subject: Microbiology Year: 2001 Type: Article Affiliation country: Argentina Institution/Affiliation country: Universidad Nacional de Córdoba/AR

Similar

MEDLINE

...
LILACS

LIS

Search on Google
Index: LILACS (Americas) Main subject: Blood Donors / HTLV-I Antibodies / HTLV-I Infections / HTLV-II Antibodies / HTLV-II Infections Type of study: Etiology study / Prognostic study / Risk factors / Screening study Limits: Adolescent / Adult / Female / Humans / Male Country/Region as subject: South America / Argentina Language: Spanish Journal: Rev. argent. microbiol Journal subject: Microbiology Year: 2001 Type: Article Affiliation country: Argentina Institution/Affiliation country: Universidad Nacional de Córdoba/AR